Deceptive Health Claims: What the FTC Expects From Med Spa Ads

Med spa marketing runs on promises: smoother skin, fewer inches, more energy, faster results. Every one of those promises is a claim the Federal Trade Commission can ask you to back up. The FTC does not pre-approve ads, but it does expect the evidence to exist before the ad goes live.

This guide covers how the FTC reads health claims, what a 2026 case against a supplement brand called TruHeight shows about weak studies and fake reviews, and a practical checklist for reviewing ads, landing pages and social posts.

The two rules behind every FTC health case

The FTC's authority comes from Sections 5 and 12 of the FTC Act, which prohibit unfair or deceptive practices and false advertising. In its Health Products Compliance Guidance, FTC staff boils this down to two principles:

Advertising must be truthful and not misleading.
Before an ad runs, the advertiser must have adequate support for every objective claim it makes, whether stated outright or implied.

For claims about health benefits or safety, that support generally means "competent and reliable scientific evidence." The guidance, published in December 2022, replaced the FTC's 1998 dietary supplement guide. Most of its examples involve supplements, but FTC staff says the same principles apply to marketing for any health-related product, including devices and apps. The guidance is staff interpretation, not a regulation, and it does not create a safe harbor.

How the FTC decides what your ad actually claims

A common mistake is reviewing only the literal words. The FTC looks at the net impression of the whole ad: the headline, the product or treatment name, the images, the before-and-after photos, the testimonials and the fine print together.

A few points from the guidance that matter for aesthetics marketing:

Implied claims count the same as express ones. You cannot suggest a benefit through images or a name that you could not state directly.
Every reasonable reading needs support. If an ad could fairly be read two ways, the advertiser is responsible for substantiating both.
Audience matters. The FTC reads claims from the viewpoint of the people targeted, and the guidance notes that some groups, such as seriously ill consumers, may be especially susceptible to exaggerated promises.
Structure and function language can imply a disease claim. Wording like "supports healthy metabolism" next to images of dramatic weight loss can convey a treatment claim the evidence has to cover.
Silence can mislead. If results depend on a diet, a series of sessions or other conditions, the ad needs to say so. The same goes for significant safety risks.
Imagery of science implies science. Lab coats, microscopes and journal covers suggest clinical proof. If you do not have it, do not imply it.

What counts as adequate evidence

There is no fixed number of studies the FTC requires. The question is whether the evidence, viewed as a whole, is enough for experts in the field to accept the claim. In practice, the guidance points to a few recurring themes:

Randomized, controlled human trials are generally expected for health benefit claims. Quality matters more than quantity.
The study has to match the claim. Same product or treatment, similar dose or protocol, a comparable population, and an outcome that actually matches what the ad promises.
Weaker evidence rarely carries a claim alone. Animal studies, lab studies, observational data and anecdotes are generally not enough on their own.
Results should be meaningful, not mined. Re-slicing data after a study fails to find a real effect is a problem the guidance specifically calls out.
"Clinically proven" raises the bar. A claim that something is proven by studies is itself a claim about the evidence, and it needs evidence at that level.

A related trap in aesthetics is regulatory status. The FDA explains that many devices reach the market through 510(k) clearance, while a smaller group of higher-risk devices goes through premarket approval. Calling a cleared device "FDA approved," or implying that a cosmetic or supplement is FDA approved, misstates its status.

The TruHeight case, briefly

In April 2026 the FTC announced an administrative complaint and proposed consent order against Vanilla Chip LLC, which does business as TruHeight, and its two co-founders. The company sold supplements marketed to help children and teens grow taller. The Commission finalized the order in July 2026.

According to the FTC:

TruHeight promoted its products through social media, search ads, email and its website, with claims such as being clinically proven to help height growth.
The company's main support was a single company-sponsored study of 32 people that, the FTC says, showed no meaningful difference between the treatment and control groups.
Thousands of five-star reviews on its site were allegedly written by employees, and the company gave free or discounted products in exchange for five-star reviews.
It allegedly used bot-run fake social media profiles to post comments on its Facebook and Instagram pages.

The FTC charged violations of the FTC Act and of its rule on consumer reviews and testimonials. The final order bars false or unsubstantiated height and growth claims, requires competent and reliable scientific evidence for other health and efficacy claims, and bans fake reviews and reviews bought on condition of a particular sentiment. It includes a $4 million judgment, suspended after a $750,000 payment based on the respondents' inability to pay. The company and its founders settled without a trial, and the allegations are the FTC's.

The lessons carry over directly to clinics. One weak study is not substantiation. And review practices are now a separate source of liability, not a side issue.

Reviews, testimonials and before-and-after photos

Patient reviews and transformation photos are core marketing assets for most med spas, which makes them a frequent risk point.

Typical results. If a testimonial or photo shows an outcome most patients will not get, the ad generally needs to make clear what results people can typically expect. A vague "results may vary" line usually does not fix a misleading impression.
Connections must be disclosed. Reviews or endorsements from staff, friends, vendors, or patients who received free or discounted treatment should disclose that connection.
No buying sentiment. The reviews rule prohibits offering incentives conditioned on a review being positive or negative. Asking every patient for honest feedback is different from rewarding five-star reviews.
No fake or suppressed reviews. Writing reviews, using fake profiles, or hiding negative reviews on your own site can all create problems under the rule.
Edited photos. Lighting, angles, makeup and editing can turn a real photo into a misleading one.

What the penalties look like

Most FTC health cases end in orders that restrict future marketing and, in some cases, require money for consumers. Civil penalties generally come into play when a business violates an FTC rule, such as the reviews rule, or an existing FTC order. The maximum civil penalty is $53,088 per violation. That figure was set in January 2025, and the FTC confirmed in September 2026 that it will keep the 2025 levels through 2026 because the 2026 inflation adjustment was cancelled.

Individual owners can be named too. In TruHeight, both co-founders were respondents, and the FTC's guidance notes it has also pursued ad agencies, endorsers and others involved in deceptive marketing.

A practical review checklist

Businesses often find it easier to run every piece of marketing through the same short set of questions before it goes live:

List the claims. Write down every benefit, result, safety statement and comparison the ad makes, including implied ones from images and names.
Match each claim to evidence. For each one, note the study or data that supports it and check that it covers the same treatment, protocol and type of patient.
Check the words "clinically proven," "FDA approved," "permanent," "no downtime" and "safe." Each makes a specific claim that needs specific support.
Review testimonials and photos. Confirm they are real, current, not altered in misleading ways, and either typical or clearly qualified.
Disclose connections. Flag reviews or posts from staff, influencers or patients who received anything of value.
Audit review requests. Make sure incentives, if any, are not tied to a positive rating, and that negative reviews are not filtered out of your own site.
Keep a file. Save the substantiation, the approved version of the ad and who signed off. It makes later questions far easier to answer.
Get counsel on the gray areas. Weight loss, GLP-1 programs, hormone therapy and anything involving disease claims are areas worth reviewing with counsel before launch.

Where NutriCove fits

NutriCove builds AI automation for med spas, including review requests, follow-up messages and booking flows. Those automated messages are marketing too, so the same rules on honest reviews and substantiated claims apply to what they say. If you want automated review requests that ask every patient for honest feedback rather than only the happy ones, see how we set up med spa automation.

Sources

This article is general information, not legal or medical advice. Talk to a qualified attorney or licensed professional about your situation.